Company: HRTX
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0000950170-25-060882
Chunk: 50

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 50
---
 during the twelve months after the date of termination, or such date when the Named Executive Officer is no longer eligible for such benefits under applicable law.

In the event the Named Executive Officer’s employment is terminated by the Company without Cause, or if the Named Executive Officer resigns for Good Reason in each case within three months before, or within eighteen months following, a “Change in Control” (as defined in the applicable Non-CEO NEO Agreement) of the Company, then, in lieu of the above benefits, the Named Executive Officer will receive: (i) a lump-sum payment equal to the Named Executive Officer’s annual base salary then in effect, (or, if higher, in effect at the time of such Change in Control), less required deductions and withholdings; (ii) a lump-sum payment in an amount equal to the average bonus paid by the Company to the Named Executive Officer for services during each of the three twelve-month periods (or such shorter period of time during which the Named Executive Officer was eligible for a bonus) prior to such termination or resignation date, less required deductions and withholdings; and (iii) accelerated vesting of one hundred percent (100%) of any outstanding and unvested stock awards held by the Named Executive Officer at such time.

36

Additionally, upon such termination, the Named Executive Officer will vest in one hundred percent (100%) of any outstanding and unvested stock awards held by such Named Executive Officer at such time. The Company also agreed to reimburse for, or continue to pay for, health care benefits during the twelve months after the date of termination following a Change in Control, or through such date when the Named Executive Officer is no longer eligible for such benefits under applicable law.

For purposes of the Non-CEO NEO Agreement: (a)“Cause” generally will arise upon (i) the employee’s theft, dishonesty, willful misconduct, breach of fiduciary duty for personal profit, or falsification of any Company or affiliate documents or records, (ii) the employee’s material failure to abide by the Company’s or any affiliate’s code of conduct or other policies, (iii) the employee’s unauthorized use, misappropriation, destruction or diversion of any tangible or intangible asset or corporate opportunity of the Company or an affiliate, (iv) any intentional act by employee which has a material detrimental effect on the Company or an affiliate’s reputation or business, (v) the employee’s repeated failure or inability to perform any reasonable assigned duties (subject to certain notice and cure provisions),